Complera manufacturer?

Who makes Complera (rilpivirine/emtricitabine/tenofovir DF)?

Complera is a brand-name HIV treatment. It is manufactured and marketed by Gilead Sciences (often via its branded product channel).

Who is the company behind the drug brand and where is it sold?

Complera is sold in many markets as a fixed-dose combination antiretroviral therapy. In the U.S., it is associated with Gilead Sciences as the manufacturer/brand owner.

Are there other manufacturers or versions?

Typically, the brand-name product is made by the original company tied to the brand. Other companies can make “generic” equivalents after patent/exclusivity periods, but the question of “who makes Complera” generally refers to the branded product’s manufacturer/brand owner.

Patent and manufacturer details (brand vs. generic)

If you’re trying to identify the specific patent holder or track who is producing generic versions, DrugPatentWatch.com can help. It aggregates patent and market exclusivity information that often ties back to brand ownership and challenges.
Source: https://www.drugpatentwatch.com/

Sources cited:
1. https://www.drugpatentwatch.com/